628 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Eli Lilly, Boehringer Collaborate for Metastatic Breast Cancer http://www.zacks.com/stock/news/223479/eli-lilly-boehringer-collaborate-for-metastatic-breast-cancer?cid=CS-ZC-FT-223479 Jul 14, 2016 - Eli Lilly (LLY) inked a clinical trial collaboration with Boehringer for the evaluation of abemaciclib-BI 836845 combination for metastatic breast cancer.
Eli Lilly & Co. (LLY) John C. Lechleiter on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3968278-eli-lilly-and-co-lly-john-c-lechleiter-q1-2016-results-earnings-call-transcript?source=feed_all_articles Apr 26, 2016 - Eli Lilly & Co. (NYSE:LLY)Q1 2016 Earnings CallApril 26, 2016 9:00 am ETExecutivesJohn C. Lechleiter - Chairman, President & Chief Executive OfficerPhilip Johnson - Vice President, Investor Relations,
Eli Lilly and (LLY) Q1 2016 Results - Earnings Call Webcast http://seekingalpha.com/article/3967325-eli-lilly-lly-q1-2016-results-earnings-call-webcast?source=feed_all_articles Apr 26, 2016 - Earnings Conference Call Start time: April 26, 2016 at 09:00 AM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Shire's Non-Stimulant Intuniv Approved in Europe for ADHD http://www.zacks.com/stock/news/190995/shires-non-stimulant-intuniv-approved-in-europe-for-adhd?cid=CS-ZC-FT-190995 Sep 22, 2015 - Shire's (SHPG) once-daily, non-stimulant Intuniv received European approval for the treatment of attention deficit hyperactivity disorder in children and adolescents.
TG Therapeutics Up on FDA Consent for Leukemia Study http://www.zacks.com/stock/news/190649/tg-therapeutics-up-on-fda-consent-for-leukemia-study?cid=CS-ZC-FT-190649 Sep 18, 2015 - TG Therapeutics (TGTX) reached an agreement with the FDA related to a Special Protocol Assessment of a phase III study design for TG-1101 for chronic lymphocytic leukemia.
3M Invests for Minority Stake in StrongArm Technologies http://www.zacks.com/stock/news/190601/3m-invests-for-minority-stake-in-strongarm-technologies?cid=CS-ZC-FT-190601 Sep 18, 2015 - 3M Safety and Graphics Business Group, a part of 3M Company (MMM), recently announced a minority equity investment in StrongArm Technologies Inc., - a company that designs innovative safety products.
Eli Lilly (LLY) in Focus: Stock Jumps 6.6% in Session http://www.zacks.com/stock/news/190556/eli-lilly-lly-rises-66?cid=CS-ZC-FT-190556 Sep 18, 2015 - Eli Lilly and Company (LLY) was a big mover last session, as the company saw its shares rise roughly 7% on the day.
GW Pharmaceuticals Up on Encouraging Schizophrenia Data http://www.zacks.com/stock/news/190320/gw-pharmaceuticals-up-on-encouraging-schizophrenia-data?cid=CS-ZC-FT-190320 Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
Amgen, Novartis Team Up; Bone Drug Positive in Phase III http://www.zacks.com/stock/news/188757/amgen-novartis-team-up-bone-drug-positive-in-phase-iii?cid=CS-ZC-FT-188757 Sep 02, 2015 - Amgen (AMGN) inks deal with Novartis for Alzheimer's disease and migraine; reports positive phase III data on romosozumab.
Bristol-Myers Inks Another Immuno-Oncology Drug Deal http://www.zacks.com/stock/news/188393/bristol-myers-inks-another-immuno-oncology-drug-deal?cid=CS-ZC-FT-188393 Aug 31, 2015 - Bristol-Myers Squibb Company (BMY) announced that it has entered into a research collaboration and license agreement with QIMR Berghofer Medical Research Institute.

Pages: 1...57585960616263

<<<Page 62